Teleflex Completes €760M Acquisition of BIOTRONIK’s Vascular Intervention Unit, Expanding Global Footprint in Cath Lab and Peripheral Markets

Wayne, PA, July 1, 2025 (GlobeNewswire) -- Teleflex has completed its €760 million acquisition of BIOTRONIK’s Vascular Intervention business, significantly expanding its global presence in both coronary and peripheral intervention markets. The acquisition brings a differentiated portfolio of drug-coated balloons, stents, and advanced catheter systems, bolstering Teleflex’s capabilities in cath labs and interventional radiology suites.

Read full article here.